These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36409726)

  • 1. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study.
    Wu YF; Gu MH; Liu CZ; Huang WH; Chu SC; Wang TF
    PLoS One; 2022; 17(11):e0278040. PubMed ID: 36409726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.
    Sandes AF; Yamamoto M; Matarraz S; Chauffaille Mde L; Quijano S; López A; Oguro T; Kimura EY; Orfao A
    Haematologica; 2012 Jun; 97(6):895-902. PubMed ID: 22271903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal platelet phenotypes in patients with myelodysplastic syndromes.
    Liu J; Niu H; Yue L; Lv Q; Yang L; Liu C; Jiang H; Xing L; Shao Z; Wang H
    Int J Lab Hematol; 2020 Aug; 42(4):371-379. PubMed ID: 32202052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
    Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower platelet count with increased density of platelet antigens in granulocyte colony-stimulating factor mobilized peripheral blood stem cell donors.
    Wu YF; Gu MH; Yang SH; Wang TF
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):204-210. PubMed ID: 31003920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
    Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload.
    Popov VM; Vladareanu AM; Bumbea H; Kovacs E; Savopol T; Iordache MM; Moisescu MG
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):743-9. PubMed ID: 25811447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
    Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
    Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
    Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
    Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
    Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
    Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
    Nkambule BB; Davison G; Ipp H
    Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative Analysis on Immunophenotype of CD34
    Chen X; Ren FG; Zhang YF; Xu J; Xia T; Chang JM; Chen XH; Tan YH; Wang HW; Xu ZF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):832-839. PubMed ID: 34105480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia.
    Blair TA; Michelson AD; Frelinger AL
    Sci Rep; 2018 Jul; 8(1):10300. PubMed ID: 29985398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
    Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
    Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation.
    Behbehani GK; Finck R; Samusik N; Sridhar K; Fantl WJ; Greenberg PL; Nolan GP
    Cytometry B Clin Cytom; 2020 Mar; 98(2):131-145. PubMed ID: 31917512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff value.
    Keller Cecconello D; Spagnol F; Alegretti AP; Pilger DA; Farias MG
    Hematol Transfus Cell Ther; 2023 Aug; ():. PubMed ID: 37652805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormality of immunophenotyping in patients with myelodysplastic syndrome].
    Xu J; Guo YX; Zhao H; Hui WH; Wan SG; Sun XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):894-7. PubMed ID: 19698224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.